Model of the BzR binding site: Correlation of data from site-directed mutagenesis and the pharmacophore/receptor model

Medicinal Chemistry Research

Volumn 10, Issue 5, 2001, Pages 269-308

  He, X ^a   Zhang, C ^a   Cook, J M ^a  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 CHLOROPHENYL) 5H PYRAZOLO[4,3 C]QUINOLIN 3 ONE; 3 METHYL 6 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 TRIAZOLO[4,3 B]PYRIDAZINE; 4 AMINOBUTYRIC ACID A RECEPTOR; 8 AZIDO 5,6 DIHYDRO 5 METHYL 6 OXO 4H IMIDAZO[1,5 A][1,4]BENZODIAZEPINE 3 CARBOXYLIC ACID ETHYL ESTER; ALPIDEM; AMINO ACID; BENZODIAZEPINE; BENZODIAZEPINE RECEPTOR; CLONAZEPAM; DIAZEPAM; FLUMAZENIL; FLUNITRAZEPAM; HYDROGEN; MIDAZOLAM; PROTEIN; TRIAZOLAM; ZOLPIDEM;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; GABAERGIC SYSTEM; HUMAN; MODEL; NONHUMAN; SEQUENCE HOMOLOGY;

EID: 0035030068     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. A receptor subtypes
2. A receptors
3. A receptor subtypes: From pharmacology to molecular biology
4. Ligand-gated ion channels in the brain: The amino acid receptor superfamily
5. A receptor shows a ligand-gated receptor super-family
6. Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family
7. Molecular diversity of the NMDA receptor channel
8. The strychnine-binding subunit of the glycine receptor shows homology with nicotinic acetylcholine receptors
9. A receptors
10. Nicotinic acetylcholine receptor at 9 Å resolution
11. Ion channel of acetylcholine receptor reconstructed from images of postsynaptic membranes
12. A receptor determined by electron microscope image analysis
13. Areceptors on channel function
14. A receptors depend upon subunit composition
15. A receptor heterogeneity
16. A receptor subunit for benzodiazepine pharmacology
17. A/benzodiazepine receptors in a transfected cell line
18. A receptor
19. Stoichiometry of a ligand-gated ion channel determined by fluorescence energy transfer
20. A-receptor heterogeneity in the adult rat brain: Differential regional and cellular distribution of seven major subunits
21. Aγ2 receptor subunit genes cluster in drug responses and the development of alcohol dependence
22. A receptor subtypes
23. Molecular and neuronal substrate for the selective attenuation of anxiety
24. A receptor α1 subtype
25. A receptor in rat brain
26. Benzodiazepine-insensitive mice generated by targeted disruption of the γ2 subunit gene of γ-aminobutyric acid type A receptors
27. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon
28. A receptors: Classification on the basis of subunit structure and receptor function
29. 3H]Ro 15-4513
30. 3H]flunitrazepam is histidine 102 of the alpha subunit
31. A receptors with flunitrazepam identifies a subset of ligands that interact directly with His102 of the α subunit and predicts orientation of these within the benzodiazepine pharmacophore
32. A receptors
33. A receptor but the α1 polypeptide is the principal site of the agonist benzodiazepine photoaffinity labeling reaction
34. Synthesis of novel 3-substituted β-carbolines as benzodiazepine receptor ligands: Probing the benzodiazepine receptor pharmacophore
35. A receptors is essential for benzodiazepine agonist binding
36. A receptors rendered diazepam-insensitive by point-mutated alpha-subunits
37. A receptor
38. A receptors
39. Structural elements of the γ-aminobutyric acid type A receptor conferring subtype selectivity for benzodiazepine site ligands
40. γ-aminobutyric acid type A receptor point mutation increases the affinity of compounds for the benzodiazepine site
41. A receptors affects the interaction with selected benzodiazepine binding site ligands
42. A receptors: Relative orientation of ligands and amino acid side chains
43. A receptors influence affinities for benzodiazepine binding site ligands
44. A receptor that determine ligand binding and modulation at the benzodiazepine site
45. A receptors drastically alter the affinity for ligands of the benzodiazepine binding site
46. A point mutation in the γ2 subunit of γ-Aminobutyric acid type A receptors results in altered benzodiazepine binding site specificity
47. A/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a comprehensive ligand-mapping approach
48. A receptor affecting modulation of the channel by ligands of the benzodiazepine site
49. A receptors
50. A receptor
51. Development of a comprehensive pharmacophore model for the benzodiazepine receptor
52. Chemical and computer assisted development of the inclusive pharmacophore of benzodiazepine receptors
53. Synthetic and computer-assisted analysis of the structural requirements for selective, high affinity ligand binding to 'diazepam-insensitive' benzodiazepine receptors
54. A receptors
55. Modeling the benzodiazepine receptor using structural and theoretical characterization of novel β-carbolines
56. Molecular yardsticks: Synthesis of higher homologs of 7,12-dihyropyrido[3,4-b:5,4-b']diindole. Probing the dimensions of the benzodiazepine receptor inverse agonist site
57. Synthetic and computer-assisted analyses of the pharmacophore for the benzodiazepine receptor inverse agonist site
58. Structural requirements for agonist actions at the benzodiazepine receptor: Studies with analogues of 6-(benzyloxy)-4-(methoxymethyl)-β-carboline-3-carboxylic acid ethyl ester
59. Synthesis of substituted 7,12-dihydropyrido[3,2-b:5,4-b'] diindoles: Rigid planar benzodiazepine receptor ligands with inverse agonist/antagonist properties
60. The agonist pharmacophore of the benzodiazepine receptor. Synthesis of a selective anticonvulsant/anxiolytic
61. Inverse agonists: Probes to study the structure, topology and function of the benzodiazepine receptor
62. Synthetic and computer assisted analysis of the pharmacophore for agonists at benzodiazepine receptors
63. Molecular yardsticks: Rigid probes to define the spatial dimensions of the benzodiazepine receptor binding site
64. Predictive binding of β-carboline inverse agonists and antagonists via the CoMFA/GOLPE approach
65. The synthesis of benzofused benzodiazepines employed as probes of the agonist pharmacophore of benzodiazepine receptors
66. Study of pharmacophore/receptor models for benzodiazepine receptor subtypes via preparation of rigidly substituted pyrazoloquinolinones
67. A/benzodiazepine receptor subtypes: Binding affinities of substituted β-carboline ligands for αxβ3γ2(x=1-3, 5, 6) subtypes and quantitative structure-activity relationship studies via comparative molecular field analysis
68. A/BzR subtypes: Binding affinities of symmetrically substituted pyrazolo[4,3-c]quinolin-3-ones at recombinant αxβ3γ2 subtypes and quantitative structure-activity relationship studies via a comparative molecular field analysis
69. 2-Arylpyrazolo[4,3-c]quinolin-3-ones: Novel agonist, partial agonist, and antagonist of benzodiazepines
70. Thienylpyrazoloquinolines with high affinity to benzodiazepine receptors: Continuous shift from inverse agonist to agonist properties depending on the size of the alkyl substituent
71. Receptor classes and the transmitter-gated channels
72. Nicotinic acetylcholine receptor superfamily of ligand-gated ion channels
73. Molecular biology of mammalian amino acid receptors
74. Acetylcholine receptor channel imaged in the open state
75. Nicotinic acetylcholine receptor at 4.6 A resolution: Transverse tunnels in the channel wall
76. Molecular modeling of ligand-gated ion channels
77. A model of the nicotinic receptor extracellular domain based on sequence identity and residue location
78. Construction of 3-helix models of the nicotinic receptor ligand binding site
79. Predicted structure of the extracellular region of ligand-gated ion-channel receptors shows SH2 and SH3-like domains forming the ligand-binding site
80. A receptors
81. 1benzodiazepine receptor antagonist
82. A receptors containing α5 subunits
83. Zolpidem, trizolam, and diazepam decrease distress vocalizations in mouse pups: Differential antagonism by flumazenil and β-CCt
84. Pharmacophore/receptor models for GABA/BzR α2β3γ2, α3β3γ2 and α4β3γ2 recombinant subtypes. Included volume analysis and comparison to α1β3γ2, α5β3γ2 and α6β3ψ2 subtypes